Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Aurobindo Pharma Limited
FDA Inspection
•Aurobindo Pharma Limited•May 10, 2022

Aurobindo Pharma Limited – FDA Inspection, May 10, 2022

Record Details

This FDA Inspection record concerns Aurobindo Pharma Limited, with an inspection on May 10, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Aurobindo Pharma Limited
Inspection Date
May 10, 2022
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · b9201ac7-5ec4-46dd-8aaf-7304c3c93094

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1169446
FDA center
Human Drugs
Project area
Drug Quality Assurance

FDA Citations

6
  1. 21 CFR 211.68(b)Computer control of master formula records
  2. 21 CFR 211.188Prepared for each batch, include complete information
  3. 21 CFR 211.63Equipment Design, Size and Location
  4. 21 CFR 211.192Extent of discrepancy, failure investigations
  5. 21 CFR 211.100(a)Absence of Written Procedures
  6. 21 CFR 211.166(a)Written program not followed

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Aurobindo Pharma Limited

8
DateClassificationOfficeProject area
February 10, 2026Not classifiedOffice of Inspections and Investigations
August 4, 2023Not classifiedOffice of Inspections and Investigations
September 27, 2019OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
June 24, 2017NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
March 13, 2015NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 8 other inspections on the company page
Other documents for Aurobindo Pharma Limited
  • FDA Inspection 1304312 - 2026-02-10
  • FDA Inspection 1242351 - 2023-08-04
  • FDA Inspection 1105823 - 2019-09-27
  • FDA Inspection 1022788 - 2017-06-24
  • FDA Inspection 927596 - 2015-03-13

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Aurobindo Pharma Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.